Menu Search
Equities

Treace Medical Concepts Inc

TMCI:NSQ

Treace Medical Concepts Inc

Actions
  • Price (USD)7.94
  • Today's Change-0.04 / -0.50%
  • Shares traded309.62k
  • 1 Year change-6.59%
  • Beta0.4577
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Treace Medical Concepts Inc's net income fell 15.68% from a loss of 42.82m to a larger loss of 49.53m despite revenues that grew 31.92% from 141.84m to 187.12m. An increase in the selling, general and administrative costs as a percentage of sales from 96.99% to 100.43% was a component in the falling net income despite rising revenues.
Gross margin80.61%
Net profit margin-30.33%
Operating margin-30.69%
Return on assets-27.15%
Return on equity-50.69%
Return on investment-32.22%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Treace Medical Concepts Inc fell by 6.49m. Cash Flow from Financing totalled 109.38m or 58.46% of revenues. In addition the company used 34.58m for operations while cash used for investing totalled 81.30m.
Cash flow per share-0.8752
Price/Cash flow per share--
Book value per share1.68
Tangible book value per share1.35
More ▼

Balance sheet in USDView more

Treace Medical Concepts Inc has a Debt to Total Capital ratio of 33.66%, a lower figure than the previous year's 38.40%.
Current ratio4.12
Quick ratio2.98
Total debt/total equity0.5074
Total debt/total capital0.3366
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.